Related references
Note: Only part of the references are listed.Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
Denis Mongin et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Pragmatic trials of pain therapies: a systematic review of methods
David Hohenschurz-Schmidt et al.
PAIN (2022)
Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology
Kim Lauper et al.
RMD OPEN (2021)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
Alison Cave et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
COMPARATIVE EFFECTIVENESS RESEARCH IN OBSERVATIONAL SETTINGS: EVALUATING TWO NEW METHODS TO ANALYSE RESPONSE RATES
Kim Lauper et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries
Gablu Kilcher et al.
RHEUMATOLOGY (2018)
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan- European TOCERRA register collaboration
Kim Lauper et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Attrition Bias Related to Missing Outcome Data: A Longitudinal Simulation Study
Antoine Lewin et al.
EPIDEMIOLOGY (2018)
Does pattern mixture modelling reduce bias due to informative attrition compared to fitting a mixed effects model to the available cases or data imputed using multiple imputation?: a simulation study
Catherine A. Welch et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Methods for handling longitudinal outcome processes truncated by dropout and death
Lan Wen et al.
BIOSTATISTICS (2018)
Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics
Thomas Frisell et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Catalogue of bias: attrition bias
David Nunan et al.
BMJ EVIDENCE-BASED MEDICINE (2018)
Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance
Daniel B. Horton et al.
JOURNAL OF RHEUMATOLOGY (2017)
Analytical results in longitudinal studies depended on target of inference and assumed mechanism of attrition
Mark Jones et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology
Maya H. Buch et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Review of inverse probability weighting for dealing with missing data
Shaun R. Seaman et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2013)
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
William G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
No Evidence of Association Between Anti-Tumor Necrosis Factor Treatment and Mortality in Patients With Rheumatoid Arthritis Results From the British Society for Rheumatology Biologics Register
Mark Lunt et al.
ARTHRITIS AND RHEUMATISM (2010)
Bias and causal associations in observational research
DA Grimes et al.
LANCET (2002)
Share Paper
